The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
After finishing at $0.13 in the prior trading day, Zomedica Corp (AMEX: ZOM) closed at $0.13, up 2.60%. In other words, the price has increased by $2.60 from its previous closing price. On the day, 4.22 million shares were traded. ZOM stock price reached its highest trading level at $0.13 during the session, while it also had its lowest trading level at $0.126.
Ratios:
Our goal is to gain a better understanding of ZOM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.15 and its Current Ratio is at 10.82. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Dawson James on January 06, 2023, initiated with a Buy rating and assigned the stock a target price of $6.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 08 ’24 when Blair Anthony K bought 150,000 shares for $0.12 per share. The transaction valued at 18,450 led to the insider holds 400,000 shares of the business.
POWERS JOHNNY D bought 100,000 shares of ZOM for $12,100 on Nov 11 ’24. The Director now owns 2,425,000 shares after completing the transaction at $0.12 per share. On Nov 11 ’24, another insider, HEATON LARRY C II, who serves as the CEO of the company, bought 100,000 shares for $0.12 each. As a result, the insider paid 12,200 and bolstered with 500,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZOM now has a Market Capitalization of 127393496 and an Enterprise Value of 42043876. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.77 while its Price-to-Book (P/B) ratio in mrq is 0.63. Its current Enterprise Value per Revenue stands at 1.612 whereas that against EBITDA is -1.43.
Stock Price History:
The Beta on a monthly basis for ZOM is 1.03, which has changed by -0.066176474 over the last 52 weeks, in comparison to a change of 0.22212577 over the same period for the S&P500. Over the past 52 weeks, ZOM has reached a high of $0.20, while it has fallen to a 52-week low of $0.12. The 50-Day Moving Average of the stock is 1.87%, while the 200-Day Moving Average is calculated to be -6.15%.
Shares Statistics:
The stock has traded on average 6.73M shares per day over the past 3-months and 11253500 shares per day over the last 10 days, according to various share statistics. A total of 979.95M shares are outstanding, with a floating share count of 962.66M. Insiders hold about 1.76% of the company’s shares, while institutions hold 8.26% stake in the company. Shares short for ZOM as of 1728950400 were 51140313 with a Short Ratio of 6.74, compared to 1726185600 on 43371169. Therefore, it implies a Short% of Shares Outstanding of 51140313 and a Short% of Float of 5.21.
